Journal
JOURNAL OF CLINICAL MEDICINE
Volume 8, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/jcm8030350
Keywords
vascular endothelial growth factor; receptor tyrosine kinases; neuropilins; epithelial-mesenchymal transition; hypoxia-inducible factor; estrogen receptor-beta; prolyl hydroxylase 2; Notch ligand Delta-like 4; focal adhesion kinases; placental growth factor-1
Categories
Funding
- National Research Foundation of Korea (NRF) - Government of Korea (MSIT) [NRF-2014M3A9B6069338]
- R&D Program for Forest Science Technology - Korea Forest Service (Korea Forestry Promotion Institute) [2017036A00-1719-BA01]
- National Research Foundation of Korea [2014M3A9B6069338] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
Ask authors/readers for more resources
The role of vascular endothelial growth factor (VEGF) in cancer cells is not limited to angiogenesis; there are also multiple factors, such as neuropilins (non-tyrosine kinases receptors), tyrosine kinases receptors, immunodeficiencies, and integrins, that interact with VEGF signaling and cause cancer initiation. By combating these factors, tumor progression can be inhibited or limited. Natural products are sources of several bioactive phytochemicals that can interact with VEGF-promoting factors and inhibit them through various signaling pathways, thereby inhibiting cancer growth. This review provides a deeper understanding of the relation and interaction of VEGF with cancer-promoting factors and phytochemicals in order to develop multi-targeted cancer prevention and treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
